After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Agenus Inc. (AGEN) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.01, or 0.67%, to $1.51. The Agenus Inc. has recorded 109,626 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that Agenus Cancels Conference Call to Discuss the Company’s Minority Cash Holdings at SVB in Light of Government’s SVB Deposit Access Announcement.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Sponsored
Stocks Info
Agenus Inc. is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $1.50 and fluctuated between $1.6500 as its day high and $1.4100 as its day low. The current market capitalization of Agenus Inc. is $502.90M. A total of 14.61 million shares were traded on the day, compared to an average of 4.22M shares.
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, AGEN has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for AGEN in the last 3 months, the mean price target is $7.06 with high estimates of $8.30 and low estimates of $5.00. In terms of 52-week highs and lows, AGEN has a high of $3.37 and a low of $1.25.
As of this writing, AGEN has an earnings estimate of -$0.21 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of -$0.19 per share and a lower estimate of -$0.23. The company reported an EPS of -$0.17 in the last quarter, which was 26.10% higher than expectations of -$0.23.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 6 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AGEN is Overweight with a score of 4.86. A total of 6 analysts rated the stock as Buy while 0 rated it as Overweight while 0 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.
